跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VEKLURY - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
VEKLURY
Authorized
STANDARD
VEKLURY
gilead sciences canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
ba214122b573064c
Company
gilead sciences canada inc
Type
Standard
Approval Details
Approval Id
ba214122b573064c
Drug Approval Canada Name
VEKLURY
Product Name
VEKLURY
Status
Marketed
Status Date
2020-10-16
Original Market Date
2020-10-16
Din
02502143
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
08:18.32
Atc Original
J05AB16 REMDESIVIR
Atc Name
j 05 ab 16
Aig Number
0162395002
Company Name
gilead sciences canada inc
Company Address
400, 6925 Century Avenue, Mississauga, Ontario, Canada, L5N 7K2
Active Ingredients
REMDESIVIR
100 MG / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
ba214122b573064c
Type
Standard
Back to Health Canada Approvals